tiprankstipranks
Trending News
More News >

MaxCyte Announces Change in Major Holdings by BlackRock

Story Highlights
MaxCyte Announces Change in Major Holdings by BlackRock

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from MaxCyte ( (MXCT) ).

MaxCyte, Inc. has announced a change in major holdings, with BlackRock, Inc. now holding 7.90% of voting rights, up from a previous 7.80%. This adjustment in BlackRock’s stake reflects a slight increase in their influence within the company, potentially impacting MaxCyte’s strategic decisions and signaling confidence from a major institutional investor.

More about MaxCyte

MaxCyte, Inc. operates in the biotechnology industry, focusing on cell engineering and providing cell-based therapies. The company is known for its proprietary cell engineering platform that supports a wide range of applications, including drug discovery and development, biomanufacturing, and cell therapy.

Find detailed analytics on MXCT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1